Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Behavioral Neurology & Neuropsychiatry
•
Primary Care
How long do you typically wait before starting anticoagulation after holding Leqembi/Kisunla in patients with cognitive impairment?
What is the typical washout period For these medications?
Related Questions
How do you counsel patients who develop DVT or atrial fibrillation requiring anticoagulation when being treated with lecanemab or donanemab?
How do you counsel non-diabetic patients who wish to start metformin to reduce the risk of developing dementia?
When do you consider using stimulants in patients with cognitive impairments secondary to traumatic brain injury?
How do you counsel patients with mild congenital myopathy about exercise limitations?
When, if ever, would you pursue genetic testing in an asymptomatic child with multiple first-degree relatives with epilepsy?
Are there specific tools that you request for an IEP of a child with dyslexia?
Do you ever utilize a steroid pulse in patients who are pregnant with status migrainosus?
What is the optimal BP target for patients with diabetes and hypertension to reduce their risk of MI/stroke?
Is there an age cutoff where you consider the risks of monoclonal antibody therapy outweigh any potential benefit(s) in early-onset dementia?
How do you distinguish pseudodementia from early Alzheimer's diease with comorbid depression?